Crawford, R., Perkins, N. B., Hobbs, D. A., & Hobbs, A. L. V. (2022). Time to defervescence evaluation for extended‐ vs. standard‐infusion cefepime in patients with acute leukemia and febrile neutropenia. Pharmacotherapy, 42(10), 798. https://doi.org/10.1002/phar.2728
Chicago Style (17th ed.) CitationCrawford, Robert, Nicholson B. Perkins, Diana A. Hobbs, and Athena L. V. Hobbs. "Time to Defervescence Evaluation for Extended‐ Vs. Standard‐infusion Cefepime in Patients with Acute Leukemia and Febrile Neutropenia." Pharmacotherapy 42, no. 10 (2022): 798. https://doi.org/10.1002/phar.2728.
MLA (9th ed.) CitationCrawford, Robert, et al. "Time to Defervescence Evaluation for Extended‐ Vs. Standard‐infusion Cefepime in Patients with Acute Leukemia and Febrile Neutropenia." Pharmacotherapy, vol. 42, no. 10, 2022, p. 798, https://doi.org/10.1002/phar.2728.